Nicolas Acquavella

887 total citations
11 papers, 383 citations indexed

About

Nicolas Acquavella is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Nicolas Acquavella has authored 11 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in Nicolas Acquavella's work include Cancer Immunotherapy and Biomarkers (6 papers), Immunotherapy and Immune Responses (4 papers) and CAR-T cell therapy research (3 papers). Nicolas Acquavella is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Immunotherapy and Immune Responses (4 papers) and CAR-T cell therapy research (3 papers). Nicolas Acquavella collaborates with scholars based in United States, Australia and Germany. Nicolas Acquavella's co-authors include Nicholas P. Restifo, Zhiya Yu, Christopher A. Klebanoff, Stephan Ariyan, Alexey Pronin, William Kevin Kelly, Deepak Narayan, Xi Chen, Harriet M. Kluger and Mario Sznol and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Nicolas Acquavella

11 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicolas Acquavella United States 8 238 229 133 54 29 11 383
Andrea Quaiser Germany 11 342 1.4× 195 0.9× 150 1.1× 78 1.4× 42 1.4× 20 459
Thérèse Liechtenstein United Kingdom 12 252 1.1× 347 1.5× 168 1.3× 59 1.1× 19 0.7× 15 505
Dan D. Vo United States 9 223 0.9× 179 0.8× 176 1.3× 65 1.2× 22 0.8× 10 389
Nao Fujieda Japan 9 242 1.0× 292 1.3× 74 0.6× 21 0.4× 15 0.5× 12 406
Carlos Luri‐Rey Spain 11 203 0.9× 218 1.0× 93 0.7× 32 0.6× 48 1.7× 21 344
Tom Hofland Netherlands 9 235 1.0× 208 0.9× 97 0.7× 52 1.0× 27 0.9× 18 430
Cathrine Lund Lorentzen Denmark 7 299 1.3× 384 1.7× 308 2.3× 54 1.0× 40 1.4× 11 628
Josephine Walton United Kingdom 5 248 1.0× 177 0.8× 180 1.4× 41 0.8× 16 0.6× 10 432
Zsuzsanna Kurgyis Germany 8 189 0.8× 177 0.8× 85 0.6× 24 0.4× 15 0.5× 12 342
Anthony Leonardi United States 6 377 1.6× 292 1.3× 139 1.0× 108 2.0× 72 2.5× 10 518

Countries citing papers authored by Nicolas Acquavella

Since Specialization
Citations

This map shows the geographic impact of Nicolas Acquavella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Acquavella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Acquavella more than expected).

Fields of papers citing papers by Nicolas Acquavella

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Acquavella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Acquavella. The network helps show where Nicolas Acquavella may publish in the future.

Co-authorship network of co-authors of Nicolas Acquavella

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Acquavella. A scholar is included among the top collaborators of Nicolas Acquavella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Acquavella. Nicolas Acquavella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Shoushtari, Alexander N., Shaheer Khan, Kimberly M. Komatsubara, et al.. (2021). A Phase Ib Study of Sotrastaurin, a PKC Inhibitor, and Alpelisib, a PI3Kα Inhibitor, in Patients with Metastatic Uveal Melanoma. Cancers. 13(21). 5504–5504. 24 indexed citations
2.
Griner, Lesley A. Mathews, Janani Sundaresan, Zhiya Yu, et al.. (2020). Identification of Small Molecule Enhancers of Immunotherapy for Melanoma. Scientific Reports. 10(1). 5688–5688. 6 indexed citations
3.
Bechter, Oliver, Jochen Utikal, Jean‐François Baurain, et al.. (2020). 391 A first-in-human study of intratumoral SAR441000, an mRNA mixture encoding IL-12sc, interferon alpha2b, GM-CSF and IL-15sushi as monotherapy and in combination with cemiplimab in advanced solid tumors. SHILAP Revista de lepidopterología. A237.2–A238. 17 indexed citations
4.
Ban, Yuguang, et al.. (2017). Molecular Effects of Stromal-Selective Targeting by uPAR-Retargeted Oncolytic Virus in Breast Cancer. Molecular Cancer Research. 15(10). 1410–1420. 28 indexed citations
5.
Katz, Matthew H. G., Gauri R. Varadhachary, Todd W. Bauer, et al.. (2017). Preliminary safety data from a randomized multicenter phase Ib/II study of neoadjuvant chemoradiation therapy (CRT) alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic cancer.. Journal of Clinical Oncology. 35(15_suppl). 4125–4125. 14 indexed citations
6.
Katz, Matthew H. G., Gauri R. Varadhachary, Nicolas Acquavella, et al.. (2015). A randomized multicenter Phase Ib/II study to assess the immunological effect of chemoradiation therapy (CRT) in combination with pembrolizumab compared to CRT alone in resectable or borderline resectable pancreatic cancer. Journal for ImmunoTherapy of Cancer. 3(Suppl 2). P167–P167. 2 indexed citations
7.
Acquavella, Nicolas, et al.. (2014). Phase II clinical trial of bevacizumab plus ixabepilone in renal cell carcinoma.. Journal of Clinical Oncology. 32(4_suppl). 427–427. 1 indexed citations
8.
Merlino, Glenn, Keith T. Flaherty, Nicolas Acquavella, et al.. (2013). Meeting report: The future of preclinical mouse models in melanoma treatment is now. Pigment Cell & Melanoma Research. 26(4). E8–E14. 25 indexed citations
9.
Klebanoff, Christopher A., Nicolas Acquavella, Zhiya Yu, & Nicholas P. Restifo. (2010). Therapeutic cancer vaccines: are we there yet?. Immunological Reviews. 239(1). 27–44. 217 indexed citations
10.
Acquavella, Nicolas, et al.. (2009). Effect of simvastatin on endothelial cell apoptosis mediated by Fas and TNF-α. Cytokine. 49(1). 45–50. 9 indexed citations
11.
Acquavella, Nicolas, Harriet M. Kluger, Leonard R. Farber, et al.. (2008). Toxicity and Activity of a Twice Daily High-dose Bolus Interleukin 2 Regimen in Patients With Metastatic Melanoma and Metastatic Renal Cell Cancer. Journal of Immunotherapy. 31(6). 569–576. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Quaiser Breakdown of academic impact, for papers by Thérèse Liechtenstein Breakdown of academic impact, for papers by Dan D. Vo Breakdown of academic impact, for papers by Nao Fujieda Breakdown of academic impact, for papers by Carlos Luri‐Rey Breakdown of academic impact, for papers by Tom Hofland Breakdown of academic impact, for papers by Cathrine Lund Lorentzen Breakdown of academic impact, for papers by Josephine Walton Breakdown of academic impact, for papers by Zsuzsanna Kurgyis Breakdown of academic impact, for papers by Anthony Leonardi
Rankless by CCL
2026